| 2025-12-10 |
详情>>
内部人交易：
Dolan John Joseph等共交易3笔
|
| 2025-11-06 |
详情>>
股本变动：
变动后总股本3076.48万股
|
| 2025-11-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-2.78美元,归母净利润-8433.6万美元,同比去年增长30.10%
|
| 2025-11-05 |
财报披露：
美东时间 2025-11-05 盘后发布财报
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益-1.32美元,归母净利润-3975.5万美元,同比去年增长40.40%
|
| 2025-05-07 |
详情>>
业绩披露：
2025年一季报每股收益-0.33美元,归母净利润-997.2万美元,同比去年增长64.01%
|
| 2025-04-28 |
股东大会：
将于2025-06-18召开股东大会
会议内容 ▼▲
- 1.To elect the three Class I director nominees named in the accompanying proxy statement to serve for terms of three years and until their respective successors are duly elected and qualified, subject to earlier resignation or removal;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025;
3.To vote to approve, on an advisory basis, the compensation of our Named Executive Officers;
4.To vote to approve an amendment and restatement of the eHealth, Inc. 2024 Equity Incentive Plan to increase the maximum number of shares of common stock that may be issued thereunder by 1,500,000 shares;
5.To transact such other business as may properly come before the Annual Meeting or at any postponement, adjournment or continuation thereof.
|
| 2025-02-27 |
详情>>
业绩披露：
2024年年报每股收益-1.19美元,归母净利润-3496万美元,同比去年增长47.44%
|
| 2024-11-06 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-4.13美元,归母净利润-1.21亿美元,同比去年增长-11.5%
|
| 2024-08-07 |
详情>>
业绩披露：
2023年中报每股收益-2.2美元,归母净利润-6096.3万美元,同比去年增长28.27%
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益-2.29美元,归母净利润-6669.9万美元,同比去年增长-9.41%
|
| 2024-05-07 |
详情>>
业绩披露：
2024年一季报每股收益-0.96美元,归母净利润-2771.1万美元,同比去年增长1.20%
|
| 2024-04-26 |
股东大会：
将于2024-06-12召开股东大会
会议内容 ▼▲
- 1.To elect the three Class III director nominees named in the accompanying proxy statement to serve for terms of three years and until their respective successors are duly elected and qualified, subject to earlier resignation or removal;
2.To vote to approve, on an advisory basis, the compensation of our Named Executive Officers;
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024;
4.To vote to approve the eHealth, Inc. 2024 Equity Incentive Plan;
5.To vote to approve an amendment to the eHealth, Inc. 2020 Employee Stock Purchase Plan to increase the maximum number of shares that may be issued by 500,000 shares;
6.To transact such other business as may properly come before the Annual Meeting or at any postponement, adjournment or continuation thereof.
|
| 2024-02-29 |
详情>>
业绩披露：
2022年年报每股收益-4.36美元,归母净利润-1.19亿美元,同比去年增长2.87%
|
| 2024-02-29 |
详情>>
业绩披露：
2023年年报每股收益-2.37美元,归母净利润-6651.5万美元,同比去年增长44.30%
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-3.88美元,归母净利润-1.08亿美元,同比去年增长18.02%
|
| 2023-05-01 |
股东大会：
将于2023-06-14召开股东大会
会议内容 ▼▲
- 1.To elect the two Class II director nominees named in the accompanying proxy statement to serve for terms of three years and until their respective successors are duly elected and qualified, subject to earlier resignation or removal;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2023;
3.To vote to approve, on an advisory basis, the compensation of our Named Executive Officers;
4.To vote to approve, on an advisory basis, the frequency of future votes on the compensation of our Named Executive Officers;
5.To transact such other business as may properly come before the Annual Meeting or at any postponement or adjournment of the Annual Meeting.
|
| 2022-05-02 |
股东大会：
将于2022-06-15召开股东大会
会议内容 ▼▲
- 1.To elect the three Class I director nominees named in the accompanying proxy statement to serve for terms of three years and until their respective successors are duly elected and qualified, subject to earlier resignation or removal;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022;
3.To vote to approve, on an advisory basis, the compensation of our Named Executive Officers;
4.To vote to approve an amendment to our Amended and Restated 2014 Equity Incentive Plan to increase the maximum number of shares that may be issued by 3,000,000 shares;
5.To transact such other business as may properly come before the Annual Meeting or at any postponement or adjournment of the Annual Meeting.
|
| 2021-11-08 |
复牌提示：
2021-11-08 09:32:52 停牌，复牌日期 2021-11-08 09:42:52
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-05-17 |
股东大会：
将于2021-06-30召开股东大会
会议内容 ▼▲
- 1.To elect the three (3) Class III director nominees named in the accompanying proxy statement to serve for terms of three years and until their respective successors are duly elected and qualified, subject to earlier resignation or removal;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2021;
3.To vote to approve, on an advisory basis, the compensation of our Named Executive Officers;
4.To transact such other business as may properly come before the Annual Meeting or at any postponement or adjournment of the Annual Meeting.
|
| 2020-04-28 |
股东大会：
将于2020-06-09召开股东大会
会议内容 ▼▲
- 1.To elect three (3) Class II directors (Andrea C. Brimmer, Beth A. Brooke and Randall S. Livingston) to serve for terms of three years and until their respective successors are duly elected and qualified, subject to earlier resignation or removal;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2020;
3.To vote to approve, on an advisory basis, the compensation of our Named Executive Officers;
4.To vote to approve the adoption of our 2020 Employee Stock Purchase Plan;
5.To transact such other business as may properly come before the Annual Meeting or at any postponement or adjournment of the Annual Meeting.
|
| 2019-04-29 |
股东大会：
将于2019-06-11召开股东大会
会议内容 ▼▲
- 1.To elect two (2) Class I directors (Scott N. Flanders and Michael D. Goldberg) to serve for terms of three years and until their respective successors are duly elected and qualified, subject to earlier resignation or removal;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2019;
3.To vote to approve, on an advisory basis, the compensation of our Named Executive Officers;
4.To vote to approve an amendment to our 2014 Equity Incentive Plan to increase the maximum number of shares that may be issued by 2,500,000 shares;
5.To transact such other business as may properly come before the Annual Meeting or at any postponement or adjournment of the Annual Meeting.
|
| 2018-04-30 |
股东大会：
将于2018-06-12召开股东大会
会议内容 ▼▲
- 1.To elect two (2) Class III directors (Jack L. Oliver, III and Ellen O. Tauscher) to serve for terms of three years and until their respective successors are duly elected and qualified, subject to earlier resignation or removal;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2018;
3.To vote to approve, on an advisory basis, the compensation of our Named Executive Officers;
4.To transact such other business as may properly come before the Annual Meeting or at any postponement or adjournment of the Annual Meeting.
|
| 2017-05-01 |
股东大会：
将于2017-06-13召开股东大会
会议内容 ▼▲
- 1. To elect one (1) Class II director (Randall S. Livingston) to serve for a term of three years and until his successor is duly elected and qualified, subject to earlier resignation or removal;
2. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2017;
3. To vote to approve, on an advisory basis, the compensation of our Named Executive Officers;
4. To vote to approve, on an advisory basis, the frequency of the voting with respect to the compensation of our Named Executive Officers;
5. To transact such other business as may properly come before the Annual Meeting or at any postponement or adjournment of the Annual Meeting.
|
| 2016-04-29 |
股东大会：
将于2016-06-16召开股东大会
会议内容 ▼▲
- 1. To elect two (2) Class I directors (Scott N. Flanders and Michael D. Goldberg) to serve for terms of three years and until their respective successors are duly elected and qualified, subject to earlier resignation or removal;
2. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2016;
3. To vote to approve, on an advisory basis, the compensation of our Named Executive Officers;
4. To transact such other business as may properly come before the Annual Meeting or at any postponement or adjournment of the Annual Meeting.
|